DK1305311T3 - Tartratsalt af thiazolidindionderivat - Google Patents

Tartratsalt af thiazolidindionderivat

Info

Publication number
DK1305311T3
DK1305311T3 DK01954159T DK01954159T DK1305311T3 DK 1305311 T3 DK1305311 T3 DK 1305311T3 DK 01954159 T DK01954159 T DK 01954159T DK 01954159 T DK01954159 T DK 01954159T DK 1305311 T3 DK1305311 T3 DK 1305311T3
Authority
DK
Denmark
Prior art keywords
tartrate salt
thiazolidinedione derivative
thiazolidinedione
derivative
tartrate
Prior art date
Application number
DK01954159T
Other languages
English (en)
Inventor
Andrew Simon Craig
Tim Chien Ting Ho
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Application granted granted Critical
Publication of DK1305311T3 publication Critical patent/DK1305311T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Cosmetics (AREA)
DK01954159T 2000-08-04 2001-08-03 Tartratsalt af thiazolidindionderivat DK1305311T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0019224.5A GB0019224D0 (en) 2000-08-04 2000-08-04 Novel pharmaceutical
PCT/GB2001/003511 WO2002012232A1 (en) 2000-08-04 2001-08-03 Tartrate salt of thiazolidinedione derivative

Publications (1)

Publication Number Publication Date
DK1305311T3 true DK1305311T3 (da) 2008-05-19

Family

ID=9897026

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01954159T DK1305311T3 (da) 2000-08-04 2001-08-03 Tartratsalt af thiazolidindionderivat

Country Status (36)

Country Link
US (1) US20040014790A1 (da)
EP (1) EP1305311B1 (da)
JP (1) JP2004505970A (da)
KR (1) KR100755174B1 (da)
CN (1) CN1455778A (da)
AP (1) AP1785A (da)
AT (1) ATE384059T1 (da)
AU (1) AU2001276506A1 (da)
BG (1) BG107604A (da)
BR (1) BR0112982A (da)
CA (1) CA2417827A1 (da)
CY (1) CY1107252T1 (da)
CZ (1) CZ2003313A3 (da)
DE (1) DE60132461T2 (da)
DK (1) DK1305311T3 (da)
DZ (1) DZ3418A1 (da)
EA (1) EA005408B1 (da)
EC (1) ECSP034467A (da)
ES (1) ES2296772T3 (da)
GB (1) GB0019224D0 (da)
HR (1) HRP20030068B1 (da)
HU (1) HUP0300778A3 (da)
IL (2) IL154275A0 (da)
MA (1) MA25832A1 (da)
MX (1) MXPA03001085A (da)
NO (1) NO324596B1 (da)
NZ (1) NZ524030A (da)
OA (1) OA12354A (da)
PL (1) PL360662A1 (da)
PT (1) PT1305311E (da)
SI (1) SI1305311T1 (da)
SK (1) SK1462003A3 (da)
UA (1) UA76720C2 (da)
WO (1) WO2002012232A1 (da)
YU (1) YU14603A (da)
ZA (1) ZA200300961B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
DE102005034406A1 (de) * 2005-07-22 2007-02-01 Ratiopharm Gmbh Neue Salze von Rosiglitazon
US7435741B2 (en) * 2006-05-09 2008-10-14 Teva Pharmaceutical Industries, Ltd. 2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
WO2017072770A1 (en) 2015-10-27 2017-05-04 Nanopass Technologies Ltd. Microneedle device with mechanical guide

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
KR20030022355A (ko) 2003-03-15
AU2001276506A1 (en) 2002-02-18
CZ2003313A3 (cs) 2004-02-18
NZ524030A (en) 2004-07-30
ES2296772T3 (es) 2008-05-01
EA200300230A1 (ru) 2003-06-26
HK1057358A1 (en) 2004-04-02
IL154275A0 (en) 2003-09-17
EP1305311A1 (en) 2003-05-02
SK1462003A3 (en) 2004-06-08
MA25832A1 (fr) 2003-07-01
CN1455778A (zh) 2003-11-12
PL360662A1 (en) 2004-09-20
PT1305311E (pt) 2008-04-07
AP1785A (en) 2007-10-04
ATE384059T1 (de) 2008-02-15
IL154275A (en) 2009-02-11
DE60132461D1 (de) 2008-03-06
CY1107252T1 (el) 2012-11-21
BR0112982A (pt) 2003-08-26
NO20030530D0 (no) 2003-02-03
JP2004505970A (ja) 2004-02-26
BG107604A (bg) 2003-09-30
SI1305311T1 (sl) 2008-04-30
AP2003002736A0 (en) 2003-03-31
WO2002012232A1 (en) 2002-02-14
US20040014790A1 (en) 2004-01-22
HUP0300778A2 (hu) 2003-11-28
MXPA03001085A (es) 2003-05-27
YU14603A (sh) 2006-05-25
OA12354A (en) 2004-03-19
EA005408B1 (ru) 2005-02-24
ZA200300961B (en) 2004-04-01
ECSP034467A (es) 2003-03-31
CA2417827A1 (en) 2002-02-14
HRP20030068B1 (en) 2008-07-31
DZ3418A1 (fr) 2002-02-14
HRP20030068A2 (en) 2005-02-28
GB0019224D0 (en) 2000-09-27
EP1305311B1 (en) 2008-01-16
NO20030530L (no) 2003-02-03
UA76720C2 (uk) 2006-09-15
KR100755174B1 (ko) 2007-09-03
HUP0300778A3 (en) 2005-04-28
DE60132461T2 (de) 2008-12-24
NO324596B1 (no) 2007-11-26

Similar Documents

Publication Publication Date Title
DK1438306T3 (da) Derivater af UK-2A
DK1360169T3 (da) Succinatsalt af O-desmethyl-venlafaxin
DK1448198T3 (da) Nicotin- eller isonicotin-benzothiazolderivater
DE50210090D1 (de) Substituierte phenylderivate
NO20025978L (no) Benzotiazol-derivater
AR028567A1 (es) Nuevos derivados de fenil-propargileter
ATE391505T1 (de) Benzothiazole derivative
AR028596A1 (es) Nuevos derivados de fenilglicina
NO20025659L (no) Heterocykliske forbindelser
PT1322592E (pt) Derivados substituidos de 1-aminobutan-3-ol
DK1305312T3 (da) Tartratsalte af thiazolidindionderivat
ATE330603T1 (de) Benzothiazolderivaten
DE60031450D1 (de) Polymorph v von torasemid
NO20030508L (no) Tartratsalter av tiazolidindionderivater
NO20030530D0 (no) Tartratsalter av tiazolidindionderivater
DK1305310T3 (da) Tartratsalte af thiazolidindionderivater
DE60219659D1 (de) Heterocyclische retioidverbindungen
SI1305310T1 (sl) Tartratne soli derivata tiazolidindiona